Immuron (IMRN) Shareholder's Equity Growth (3y) (2020 - 2025)

Immuron (IMRN) Shareholder's Equity Growth (3y) (2020 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Immuron 921.61 Mn 921.58 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 -32.23%
Jun 30, 2024 -25.11%
Jun 30, 2023 52.47%
Jun 30, 2022 47.73%
Jun 30, 2021 46.14%
Jun 30, 2020 -9.19%